SHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES has a total of 17 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AZ UNIV AMSTERDAM, PHILADELPHIA CHILDREN HOSPITAL and CHILDRENS HOSPITAL PHILADELPHIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | China | 3 | |
#3 | Republic of Korea | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Medical technology | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Peptides | |
#7 | Object sterilising | |
#8 | Specific computer systems | |
#9 | Heterocyclic compounds | |
#10 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Wang Ying | 3 |
#2 | Shi Yufang | 3 |
#3 | Sun Yu | 3 |
#4 | Wang Zefeng | 2 |
#5 | Zheng Chunxing | 2 |
#6 | Ding Qiurong | 2 |
#7 | Xie Qing | 1 |
#8 | Feng Zhuanghui | 1 |
#9 | Wang Xuefeng | 1 |
#10 | Fan Xiaojuan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021052286A1 | New exosome-releasing-related targets and use thereof in monitoring and inhibiting tumors | |
WO2021047607A1 | Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases | |
WO2021036807A1 | Application of class of small rna molecules and analogues thereof in anti-aging | |
WO2020143424A1 | Gastrointestinal stromal tumor target depdc5 and application thereof in diagnosis and treatment | |
CN111434353A | RAS inhibitor screening and therapeutic effect marker | |
CN111434337A | Use of rhodanine derivatives for the treatment of metabolic disorders | |
CN111329864A | Quinazolinone compounds and uses thereof |